379 filings
Page 6 of 19
8-K
7fto14p7
22 Mar 18
ARCA Biopharma announces fiscal year 2017 financial results AND Provides Corporate update
12:00am
8-K
lo1pkab0eotbo
5 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
hqixmxww66 9k0o2f
26 Feb 18
ARCA Biopharma reports topline Phase 2b results for genetic-af clinical trial
12:00am
8-K
is9js15
8 Jan 18
ARCA Biopharma announces completion of genetic-af Phase 2b clinical trial
12:00am
8-K
hx015mswes5vn sb43
16 Nov 17
ARCA Plans Genetically-Targeted Development of a New Chemical Entity (AB171) for Peripheral Arterial Disease and Heart Failure
12:00am
8-K
dsf09
9 Nov 17
ARCA Biopharma announces THIRD quarter 2017 financial results
12:00am
8-K
jhfk1oi
21 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
0d38dnxhkuf630nd6
16 Aug 17
Other Events
12:00am
8-K
374qfr twe
9 Aug 17
ARCA Estimates Reporting Top-line Phase 2B Data in the First Quarter of 2018
12:00am
8-K
0ap7 vth1o2x4kh
3 Aug 17
ARCA Biopharma announces SECOND quarter 2017 financial results
12:00am
8-K
utt735v
20 Jun 17
ARCA Biopharma announces database lock for genetic-af
12:00am
8-K
xl6bhizog3i6nyu2z
5 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
uh4j77vuijbqe
15 May 17
ARCA Biopharma announces first quarter 2017 financial results
12:00am
8-K
11qavsi9 34i
26 Apr 17
ARCA Biopharma announces 200th patient randomized into the GENETIC-AF SEAMLESS design Phase 2B/3 clinical trial
12:00am
8-K
g9z7cn67
21 Mar 17
ARCA Biopharma announces fiscal year 2016 financial results and provides business update
12:00am
8-K
dgp1v60
6 Mar 17
ARCA Biopharma announces 175th patient randomized into the GENETIC-AF Phase 2B/3 clinical trial
12:00am
8-K
55s4qodgd i7l6f2384h
1 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
vwmc8gj
21 Feb 17
Anders Hove, MD joins arca biopharma board of directors
12:00am
8-K
emgxfc5z
18 Jan 17
Other Events
12:00am
8-K
nuv6gp3uk7 1j
11 Jan 17
Entry into a Material Definitive Agreement
12:00am